Table 1 Baseline characteristics.

From: Identification of plaque ruptures using a novel discriminative model comprising biomarkers in patients with acute coronary syndrome

 

Rupture group (n = 42)

Non-rupture group (n = 43)

p-value

Age, years

60.2 ± 11.5

62.7 ± 11.6

0.3253

Male sex

37 (88.1)

30 (69.8)

0.0387

BMI, kg/m2

24.0 (22.9–26.7)

23.4 (21.6–26.1)

0.0787

Clinical diagnosis

0.0825

Unstable angina

23 (54.8)

33 (76.7)

 

NSTEMI

7 (16.7)

5 (11.6)

 

STEMI

12 (28.6)

5 (11.6)

 

Diabetes mellitus

12 (28.6)

6 (14.0)

0.0991

Hypertension

25 (59.6)

22 (51.2)

0.4382

Dyslipidemia

41 (97.6)

43 (100.0)

0.3088

Smoking

0.1135

Smoker

23 (54.8)

14 (32.6)

 

Ex-smoker

1 (2.4)

1 (2.3)

 

Never smoker

18 (42.9)

28 (65.1)

 

Previous PCI

8 (19.1)

7 (16.3)

0.7378

Previous CVA

1 (2.4)

3 (4.0)

0.3171

Creatinine, mg/dL

1.05 (0.82–1.2)

0.95 (0.83–1.06)

0.1112

Pro BNP, pg/mL

158.5 (44.1–709.6)

81.3 (19.5–610.3)

0.4824

WBC, × 103/μL

8.37 (7.04–11.46)

6.82 (5.79–8.8)

0.0098

Ejection fraction, %

60 (50–60)

60 (57–60)

0.1222

Total cholesterol, mg/dL

172 (59–213)

168 (130.5–201)

0.8109

LDL-cholesterol, mg/dL

113 (101–159)

111.5 (96–151)

0.5698

HDL-cholesterol, mg/dL

44.5 (35.5–83)

49 (41–62)

0.4223

Triglyceride, mg/dL

116 (89–169)

97 (66–138)

0.1403

  1. Data are presented as mean ± SD or median (interquartile range) or n (percentage).
  2. BMI body mass index, NSTEMI non-ST-segment elevation myocardial infarction, STEMI ST-segment elevation myocardial infarction, PCI percutaneous coronary intervention, CVA cerebrovascular accidents, BNP B-type natriuretic peptide, WBC white blood cell, LDL low-density lipoprotein, HDL high-density lipoprotein.
Back to article page